← Back
Data updated: Mar 10, 2026
ENCUBE
DermatologyOncologyImmunology
ENCUBE is a generic drug manufacturer focused on Dermatology, Oncology, Immunology. Key products include TESTOSTERONE.
2003
Since
36
Drugs
-
Trials
373
Approved (2yr)
Key Drugs
Recent Activity
MUPIROCIN 2026-02-24
Labeling
MUPIROCIN 2026-02-24
Labeling
MUPIROCIN 2026-02-24
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
FLUOROURACIL 2026-02-10
Labeling
TRETINOIN 2026-02-10
FLUOROURACIL 2026-02-10
Labeling
LIDOCAINE 2026-02-09
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 43%
6 drugs
Oncology 29%
4 drugs
Immunology 14%
2 drugs
Gastroenterology 7%
1 drugs
Cardiovascular 7%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular, Gastroenterology
COSETTE other
Cardiovascular, Dermatology, Immunology, Oncology
Novartis big-pharma
Oncology, Cardiovascular, Immunology
Merck big-pharma
Oncology, Cardiovascular, Immunology
Active (22)
TRETINOIN MICROSPHERE TAVABOROLE HALCINONIDE ADAPALENE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND TRETINOIN IMIQUIMOD CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE TACROLIMUS MESALAMINE FLUTICASONE PROPIONATE MUPIROCIN KETOCONAZOLE CICLOPIROX ESTRADIOL DICLOFENAC SODIUM CLINDAMYCIN PHOSPHATE BETAMETHASONE DIPROPIONATE NITROGLYCERIN DAPSONE FLUOCINONIDE ERYTHROMYCIN FLUOROURACIL
Discontinued (12)
Company Info
- First Approval
- 2003-08-27
- Latest
- 2026-02-10
- Applications
- 59